Biomarin Pharmaceutical Inc (BMRN) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Biomarin Pharmaceutical Inc  (NASDAQ: BMRN)
 

Biomarin Pharmaceutical Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Biomarin Pharmaceutical Inc's Inventory turnover ratio has remained unchanged compare to previous quarter at 0.57 in the third quarter 2026Average processing period, for Biomarin Pharmaceutical Inc's inventories remained unchanged at 640 days, in the Sep 30 2026 quarter.

Within Healthcare sector 350 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 680 in the second quarter 2026, to 1899.

BMRN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Biomarin Pharmaceutical Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BMRN Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 29.95 % 33.01 % -0.13 % 5.37 % 17.2 %
Y / Y Cost of Sales Growth 46.64 % 35.12 % 28.66 % 102.52 % -25.67 %
Inventory Turnover Ratio (TTM) 0.57 0.57 0.57 0.54 0.44
BMRN's Total Ranking # 1899 # 680 # 1395 # 464 #
Average inventory processing period 639 643 635 674 826
Seq. Inventory Growth 0.76 % 40 % -1.98 % -6.03 % 3.13 %
Seq. Cost of Sales Growth 1.29 % 4 % -29.27 % 96.82 % -6.67 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 110
Healthcare Sector # 351
Overall Market # 1899

Inventory Turnover Ratio Statistics
High Average Low
0.81 0.61 0.44
(Mar 31 2011)   (Sep 30 2025)



BMRN Company Profile >> Back to BMRN Efficiency Comparisons >> Compare BMRN Inventory Turnover Ratio to its Competitors

Financial Statements
Biomarin Pharmaceutical Inc's Inventories $ 1,796 Millions Visit BMRN's Balance sheet
Biomarin Pharmaceutical Inc's Cost of Revenues TTM $ 879 Millions Visit BMRN's Income Statement
What are BMRN's Sales? Visit BMRN's Sales by Segment

Other Inventory Turnover Ratios
Biomarin Pharmaceutical Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BMRN's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BMRN's Competitors
Inventory Turnover Ratio for BMRN's Suppliers
Inventory Turnover Ratio for BMRN's Customers

You may also want to know
BMRN's Sales Growth Rates BMRN's Pe Price to earnings ratio BMRN's Receivables Turnover Ratio BMRN's Stock Quote
BMRN's Net Income Growth Rates BMRN's Ps Price to Sales ratio BMRN's Sales per Employee BMRN's Asset Turnover Ratio
BMRN's Net Margin BMRN's Pb Price to Book ratio BMRN's Financial Strength Ratios BMRN's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Aurinia Pharmaceuticals Inc   1.29 $ 30.165  Millions$ 23  Millions
Alphatec Holdings Inc   1.27 $ 241.341  Millions$ 189  Millions
Bridgebio Pharma Inc   1.24 $ 53.542  Millions$ 43  Millions
Biogen Inc   1.23 $ 2,681.800  Millions$ 2,181  Millions
Kiniksa Pharmaceuticals International Plc  1.21 $ 93.072  Millions$ 77  Millions
Penumbra Inc  1.13 $ 499.548  Millions$ 443  Millions
Neurocrine Biosciences Inc   1.07 $ 81.200  Millions$ 76  Millions
Amarin Corp Plcuk  0.92 $ 104.502  Millions$ 113  Millions
Eli Lilly And Company  0.89 $ 14,149.700  Millions$ 15,815  Millions
Cerus Corporation  0.87 $ 54.000  Millions$ 62  Millions
Inspire Medical Systems inc   0.74 $ 122.959  Millions$ 165  Millions
Butterfly Network Inc   0.62 $ 37.120  Millions$ 60  Millions
Regeneron Pharmaceuticals Inc   0.60 $ 1,842.200  Millions$ 3,071  Millions
Orthopediatrics Corp  0.50 $ 68.827  Millions$ 137  Millions
Travere Therapeutics Inc   0.40 $ 9.545  Millions$ 24  Millions

Date modified: 2026-11-04T10:10:28+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.